Prescription Drug Monitoring Program
RULE NOS.:RULE TITLES:
64K-1.002American Society for Automation in Pharmacy Standards and Formats
64K-1.003Accessing Database
NOTICE OF CHANGE
Notice is hereby given that the following changes have been made to the proposed rule in accordance with subparagraph 120.54(3)(d)1., F.S., published in Vol. 44 No. 153, August 7, 2018 issue of the Florida Administrative Register.
The changes are in response to written comments submitted by the staff of the Joint Administrative Procedures Committee and comments received during public hearing held on August 23, 2018. Form DH8009 was amended to correct the effective date, the form number at the bottom of several pages and to correct a citation to 64K-1.003(4)(a). Form DH8012 was amended to correct a reference to Form DH 8017 in Appendix 3 and a citation to rule 64K-1.003(6)(d). Form DH 8021 was amended to correct the form number at the bottom of several pages, to correctly display form DH8022, to remove the affirmation requirement, and correct the citation to 893.055(5)(e).
64K-1.002 American Society for Automation in Pharmacy Standards and Formats.
The format for submission to the E‑FORCSE® database shall be in accordance with the electronic reporting standards of the American Society for Automation in Pharmacy (ASAP) contained in the “Implementation Guide ASAP Standard for Prescription Drug Monitoring Programs Version 4, Release 2A” (10/2016), incorporated by reference. E‑FORCSE® will continue to accept reports in the ASAP 2011 version 4.2 standard, incorporated by reference, for one year from the effective date of this rule (to be determined), after which all reports must be made using the ASAP 2016 version 4.2A standard. The format for submission to the E‑FORCSE® database if no controlled substances are dispensed shall be in accordance with the incorporated by reference ASAP Error and Zero Report Standard (10/2016). The agency has determined that posting the incorporated materials would be a violation of federal copyright law. The materials are available for public inspection at the Department of Health, 4052 Bald Cypress Way, Tallahassee, FL 32399, and the Department of State, R.A. Gray Building, 500 South Bronough Street, Tallahassee, FL 32399. A copy of the electronic reporting Standard for Prescription Drug Monitoring Programs may be obtained from the American Society for Automation in Pharmacy, 492 Norristown Road, Suite 160, Blue Bell, Pennsylvania 19422, Telephone: (610)825-7783, Website: www.asapnet.org.
64K-1.003 Accessing Database.
(1) Definitions:
(a) through (d) No change.
(e) “Order” means a written, transmitted or oral direction from a prescriber for a controlled substance to be administered to a patient in an inpatient setting.
(f) No change.
(2) through (8) No change.
